Comvita Completes Licensing Deal with Derma
Feb. 24 (BusinessWire) – Comvita Ltd. the medicinal honey products developer whose shares have doubled in 12 months, said it completed a global licensing and manufacturing deal with Nasdaq-listed Derma Science Inc. for its Medihoney wound-care line.
…Under the agreement, Derma gets exclusive worldwide rights to manufacture and sell the Medihoney range, which uses `medical grade’ manuka honey, to the professional and medical market…
Derma chairman Ed Quilty said the deal will “leverage Comvita’s ample supply of manuka honey” to expand Derma’s Advanced Wound Care product line in coming years.
Derma will expand its global presence as a result and is bolstering its sales force and hiring a managing director for Europe.